Improving outcomes with bivalirudin in primary percutaneous coronary intervention

被引：0
|
作者：
Stone, Gregg W. [1 ,2 ]
机构：
[1] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA
[2] Cardiovasc Res Fdn, New York, NY USA
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷 / 34期
关键词：
ELEVATION MYOCARDIAL-INFARCTION; GLYCOPROTEIN IIB/IIIA INHIBITOR; STENT THROMBOSIS; CLOPIDOGREL PRETREATMENT; HEPARIN MONOTHERAPY; CLINICAL-OUTCOMES; PRIMARY PCI; ABCIXIMAB; THERAPY; METAANALYSIS;
D O I：
10.1093/eurheartj/ehu227
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2269 / 2272
页数：4
相关论文
共 50 条
  • [11] Impact of Bivalirudin Use on Outcomes in Nonagenarians Undergoing Percutaneous Coronary Intervention
    Lemesle, Gilles
    Bonello, Laurent
    De Labriolle, Axel
    Steinberg, Daniel H.
    Roy, Probal
    Slottow, Tina L. Pinto
    Torguson, Rebecca
    Kaneshige, Kimberly
    Xue, Zhenyi
    Suddath, William O.
    Satler, Lowell F.
    Kent, Kenneth M.
    Lindsay, Joseph
    Pichard, Augusto D.
    Waksman, Ron
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2009, 22 (01) : 61 - 67
  • [12] Bivalirudin, glycoprotein inhibitor, and heparin use and association with outcomes of primary percutaneous coronary intervention in the United Kingdom
    Sirker, Alex
    Mamas, Mamas
    Robinson, Derek
    Anderson, Simon G.
    Kinnaird, Tim
    Stables, Rod
    de Belder, Mark A.
    Ludman, Peter
    Hildick-Smith, David
    EUROPEAN HEART JOURNAL, 2016, 37 (16) : 1312 - 1320
  • [13] Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes
    Bates E.R.
    Current Cardiology Reports, 2001, 3 (5) : 348 - 354
  • [14] Bivalirudin versus Heparin in Primary Percutaneous Coronary Intervention- a Meta analysis
    Narayanan, Mahesh Anantha
    Reddy, Yogesh N. V.
    Anugula, Dixitha
    Gujjula, Nagarjuna
    Badheka, Apurva
    Deshmukh, Abhishek
    Kaushik, Manu
    Raveendran, Ganesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B64 - B64
  • [15] Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention
    Watson, Kristin
    Seybert, Amy L.
    Saul, Melissa I.
    Lee, Joon Sup
    Kane-Gill, Sandra L.
    PHARMACOTHERAPY, 2007, 27 (05): : 647 - 656
  • [16] Bivalirudin in Percutaneous Coronary Intervention, is it the Anticoagulant of Choice?
    Mahmoud, Ahmed
    Saad, Marwan
    Elgendy, Akram Y.
    Abuzaid, Ahmed
    Elgendy, Islam Y.
    CARDIOVASCULAR THERAPEUTICS, 2015, 33 (04) : 227 - 235
  • [17] Platelet Activity in Primary Percutaneous Coronary Intervention Patients Randomized to Bivalirudin or Heparin
    Venetsanos, Dimitrios
    Swahn, Eva
    Lawesson, Sofia Sederholm
    Gustafsson, Kerstin M.
    Erlinge, David
    Lindahl, Tomas L.
    Alfredsson, Joakim
    CIRCULATION, 2017, 136
  • [18] Bivalirudin is associated with better clinical outcomes as opposed to unfractionated heparin in patients undergoing primary percutaneous coronary intervention
    Ferdous, M. D. Misbahul
    Sun, Haihui
    Sumon, Chowdhury
    Wang, Xiaotian
    Pan, Zhixiang
    Zhu, Haijun
    Shahbaz, Muhammad
    Zhao, Yuying
    Cui, Lianqun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (02): : 3425 - 3434
  • [19] Bivalirudin Use for Primary Percutaneous Coronary Intervention on Long-Term Mortality
    Caturano, Alfredo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 78 (01) : 3 - 4
  • [20] Bivalirudin during percutaneous coronary intervention in acute coronary syndromes
    Laine, Marc
    Lemesle, Gilles
    Dabry, Thibaut
    Panagides, Vassili
    Peyrol, Michael
    Paganelli, Franck
    Bonello, Laurent
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (03) : 295 - 304
12345